CORRECT: ACADIA PHARMA: ACP-104 MISSED PRIMARY ENPOINT IN PHASE IIB TRIAL (Acadia Pharmaceutica)

Date : 16/06/2008 @ 12:55
Source : TFN
Stock : Acadia Pharmaceutica (ACAD)
Quote : 1.77  -0.33 (-15.71%) @ 21:40
<< BackQuote Chart Financials

 



CORRECT: ACADIA PHARMA: ACP-104 MISSED PRIMARY ENPOINT IN PHASE IIB TRIAL (Acadia Pharmaceutica)

        (Earlier headline did not label endpoint)
    NEW YORK (Thomson Financial) - 
Chuck Mikolajczak
cm/cm

COPYRIGHT

Copyright Thomson Financial News Limited 2007. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content,
including by framing or similar means, is expressly prohibited without the prior
written consent of Thomson Financial News.

<< Back


Acadia Pharmaceutica Historical Chart Acadia Pharmaceutica Intraday Chart  
Period


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: :: Press office ::
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services The CFD Trading Centre ADVFN Bookshop - Click here Spread Betting - The Spread Betting Trading Centre Money Words - ADVFN Financial Glossary
41 site:2gb 081006 22:41